L. Mary Smith - 04 Jan 2024 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jan 2024, 21:13:06 UTC
Prior SEC filing
05 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact

Key filing fact

L. Mary Smith filed Form 4 for SpringWorks Therapeutics, Inc. (SWTX) on 08 Jan 2024.

Key facts

  • This page summarizes L. Mary Smith's Form 4 filing for SpringWorks Therapeutics, Inc. (SWTX).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Jan 2024, 21:13.

Change

  • Previous filing in this sequence was filed on 05 Jul 2023.
  • Current net transaction value: -$230,207.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SWTX transaction

Common Stock

Award

Transaction value
$0
Shares
+21,156
Change %
+9.7%
Price
$0.000000
Shares after
239,095
Date
04 Jan 2024
Ownership
Direct
Footnotes
F1
SWTX transaction

Common Stock

Tax liability

Transaction value
$83,398
Shares
-2,197
Change %
-0.92%
Price
$37.96
Shares after
236,898
Date
05 Jan 2024
Ownership
Direct
Footnotes
F2
SWTX transaction

Common Stock

Tax liability

Transaction value
$146,809
Shares
-3,535
Change %
-1.5%
Price
$41.53
Shares after
233,363
Date
08 Jan 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SWTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+60,000
Change %
Price
$0.000000
Shares after
60,000
Date
04 Jan 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$38.40
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.

Footnote F2

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person.

Footnote F3

This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .